Effects of ω-conotoxin GVIA on cardiac sympathetic nerve function

Journal of the Autonomic Nervous System

Volumn 68, Issue 1-2, 1998, Pages 43-48

  Yahagi, Naoki ^a   Akiyama, Tsuyoshi ^a   Yamazaki, Toji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Calcium channel; Cat; Microdialysis; Noradrenaline release

Indexed keywords

CALCIUM CHANNEL; OMEGA CONOTOXIN;

ANIMAL EXPERIMENT; ARTICLE; CAT; EXOCYTOSIS; HEART INNERVATION; MICRODIALYSIS; NERVE ENDING; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; SYMPATHETIC INNERVATION;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CATS; DESIPRAMINE; ELECTRIC STIMULATION; HEART; HEMODYNAMIC PROCESSES; MICRODIALYSIS; NOREPINEPHRINE; OMEGA-CONOTOXIN GVIA; PEPTIDES; SYMPATHETIC NERVOUS SYSTEM; TYRAMINE;

EID: 0032545629     PISSN: 01651838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1838(97)00120-3     Document Type: Article

References (26)

1. Akiyama T., Yamazaki T., Ninomiya I. In vivo monitoring of myocardial interstitial norepinephrine by dialysis technique. Am. J. Physiol. 261:1991;H1643-H1647.
2. Anton A.H., Sayer D.F. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamine. J. Pharmacol. Exp. Ther. 138:1962;360-370.
3. Blaustein M.P. Calcium transport and buffering in neurons. Trends Neurosci. 11:1988;438-443.
4. H. Bönisch, U. Trendelenburg, The mechanism of action of indirectly acting sympathomimetic amines, in: U. Trendelenburg, N. Weiner (Eds.), Handbook of experimental pharmacology, vol. 90/1, Catecholamine 1, Springer, Berlin, Heidelberg, New York, 1988, pp. 246-277. .
5. Clasbrummel B., Osswald H., Illes P. Inhibition of noradrenaline release by ω-conotoxin GVIA in the rat tail artery. Br. J. Pharmacol. 96:1989;101-110.
6. Eisenhofer G., Smolich J.J., Cox H.S., Esler M.D. Neuronal reuptake of norepinephrine and production of dihydroxyphenylglycol by cardiac sympathetic nerves in the anesthetized dog. Circulation. 84:1991;1354-1363.
7. Goldstein D.S., Eisenhofer G., Stull R., Folio C.J., Keiser H., Kopin I. Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans. J. Clin. Invest. 81:1988;213-222.
8. Haass M., Förster C., Richardt G., Kranzhöfer R., Schömig A. Role of calcium channels and protein kinase C for release of norepinephrine and neuropeptide Y. Am. J. Physiol. 259:1990;R925-R930.
9. Hirning L.D., Fox A.P., McCleskey E.W., Olivera B.M., Thayer S., Miller R.J., Tsien R.W. Dominant role of N-type calcium channels in evoked release of norepinephrine from sympathetic neurons. Sci. Wash. DC. 239:1988;57-61.
10. Kopin I.J. Catecholamine metabolism: Basic aspects and clinical significance. Pharmacol. Rev. 37:1985;333-364.
11. Kranzhöfer R., Haass M., Kurz T., Richardt G., Schömig A. Effect of digitalis glycosides on norepinephrine release in the heart. Circ. Res. 68:1991;1628-1637.
12. Kurz T., Richard G., Hagl S., Seyfarth M., Schömig A. Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue. J. Mol. Cell Cardiol. 27:1995;1161-1172.
13. Luca A.D., Li C.G., Rand M.J., Reid J.J., Thaina P., Wong-Dusting H.K. Effects of ω-conotoxin GVIA on autonomic neuroeffector transmission in various tissues. Br. J. Pharmacol. 101:1990;437-447.
14. Pruneau D., Angus J.A. ω-Conotoxin GVIA is a potent inhibitor of sympathetic neurogenic responses in rat small mesenteric arteries. Br. J. Pharmacol. 100:1990;180-184.
15. Pruneau D., Angus J.A. ω-Conotoxin GVIA, the N-type calcium channel inhibitor, is sympatholytic but not vagolytic: Consequences for hemodynamic and autonomic reflexes in conscious rabbits. J. Cardiovasc. Pharmacol. 16:1990;675-680.
16. Pruneau D., Bélichard P. Haemodynamic and humoral effects of ω-conotoxin GVIA in normotensive and spontaneously hypertensive rats. Eur. J. Pharmacol. 211:1992;329-335.
17. Pullar I.A., Findlay J.D. Effect of voltage-sensitive calcium channel antagonists on the release of 5-hydroxytryptamine from rat hippocampus in vivo. J. Neurochem. 59:1992;553-559.
18. Richardt G., Haass M., Schömig A. Calcium antagonists and cardiac noradrenaline release in ischemia. J. Mol. Cell Cardiol. 23:1991;269-277.
19. Schömig A., Rehmert G., Kurz T., Richardt G. Calcium antagonism and norepinephrine release in myocardial ischemia. J. Cardiovasc. Pharmacol. 20(suppl. 7):1992;S16-S20.
20. Shindo T., Akiyama T., Yamazaki T., Ninomiya I. Regional myocardial interstitial norepinephrine kinetics during coronary occlusion and reperfusion. Am. J. Physiol. 270:1996;H245-H251.
21. Terland O., Grønberg M., Flatmark T. Catecholamine releasing effect of calcium channel blockers: Inhibition of the bioenergetics of catecholamine storage vesicles. J. Mol. Cell Cardiol. 22:1990;S14.
22. Tsien R.W., Lipscombe D., Madison D.V., Bley K.R., Fox A.P. Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci. 11:1988;431-438.
23. 2+-mediated injury in CNS white matter. Trends Neurosci. 10:1991;461-466.
24. Yamazaki T., Akiyama T., Shindo T. Routine high-performance liquid chromatographic determination of myocardial interstitial norepinephrine. J. Chromatogr. B. 670:1995;328-331.
25. Yamazaki T., Akiyama T. Effects of locally administered desipramine on myocardial interstitial norepinephrine levels. J. Auton. Nerv. Syst. 61:1996;264-268.
26. Yamazaki T., Akiyama T., Kitagawa H., Takauchi Y., Kawada T., Sunagawa K. A new, concise approach to assessment of cardiac sympathetic nerve terminal abnormalities. Am. J. Physiol. 272:1997;H1182-H1187.